Rectal Cancer
Rectal cancer is a type of cancer that develops in the rectum, the final section of the large intestine. It can cause symptoms such as rectal bleeding, changes in bowel habits, and abdominal discomfort.
Rectal Cancer Surgery: SGM-101 Imaging Study
We are testing a new imaging agent, SGM-101, to see if it helps surgeons better detect rectal cancer during surgery. This study is for patients with locally advanced or recurrent rectal cancer who are undergoing curative surgery.
>2 years≤5 visitsEfficacy phase (II)No PlaceboInvestigational MedicinesInjectionGastroenterologyOncology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have locally advanced rectal cancer (T3 or T4) or recurrent rectal cancer?
- Are you pregnant or breastfeeding?
- Do you have a history of significant allergies?
- Have you had any other cancers in the past five years, except for certain skin cancers?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sgm-101
Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC Stichting
Surgery
Abcoude, Netherlands
Catharina Ziekenhuis Stichting
Surgery
Eindhoven, Netherlands
Universitair Medisch Centrum Groningen
Surgery
Groningen, Netherlands
Sponsor: Academisch Ziekenhuis Leiden
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.